Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inverness becomes Alere

This article was originally published in The Gray Sheet

Executive Summary

Inverness Medical Innovations plans to change its name to Alere as part of a strategy to leverage its combined offerings and maximize visibility and growth, the firm announces May 18. The diagnostics and health management services firm currently uses the Alere name (which means "to nurture" in Latin) for its health management services. "Therefore, the name already benefits from recognition within the healthcare community," the firm says. Inverness acquired health management services firm Alere in 2007 and will seek shareholder approval for the name change at its July 14 annual meeting; the company's stock symbol would change from "IMA" to "ALR" (1"The Gray Sheet" Oct. 29, 2007)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028916

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel